Why the new Alzheimer's drug was approved by fast track by the US FDA when it shows no cognitive benefit for patients and the scientific history behind it.
Alzheimer's, Aduhelm, and the amyloid hypothesis.
Alzheimer's, Aduhelm, and the amyloid…
Alzheimer's, Aduhelm, and the amyloid hypothesis.
Why the new Alzheimer's drug was approved by fast track by the US FDA when it shows no cognitive benefit for patients and the scientific history behind it.